Charlotte D. Champagne
Beth Israel Deaconess Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Charlotte D. Champagne.
Journal of Parenteral and Enteral Nutrition | 1990
Rk Stuart; Scott A. Shikora; P Akerman; Jeffrey A. Lowell; John K. Baxter; Caroline M. Apovian; Charlotte D. Champagne; A Jennings; Mary Keane-Ellison; Bruce R. Bistrian
The risk of complication during the insertion or exchange of central venous catheters has been well documented. The majority of complications involve mechanical problems associated with insertion. Although cardiac arrhythmia has been acknowledged as a possible complication, its incidence has never been quantified. We performed cardiac monitoring on patients during 51 central venous catheter insertions or exchanges to determine the incidence of cardiac arrhythmias during guidewire insertion. Forty-one percent of procedures resulted in atrial arrhythmias and 25% produced some degree of ventricular ectopy, 30% of these were ventricular couplets or greater. Ventricular ectopy was significantly more common in shorter patients (160 +/- 8 vs 168 +/- 11 cm, p less than 0.05) and when the catheter was inserted from the right subclavian position (43% ventricular ectopy vs 10% at the other sites). Other variables such as age, cardiac history, serum potassium, type of procedure, and catheter brand were not significant. It is our conclusion that over-insertion of the wire causes this cardiac stimulation. Despite the absence of morbidity or mortality in this study, this incidence of ventricular ectopy indicates that there is a distinct possibility of a malignant arrhythmia being precipitated by a guidewire. Some modification of the current protocol for these procedures seems indicated.
Journal of Parenteral and Enteral Nutrition | 1984
Richard J. Baptista; Bruce R. Bistrian; George L. Blackburn; Donald G. Miller; Charlotte D. Champagne; L Buchanan
The selenium status of 13 adult home parenteral nutrition (HPN) patients was evaluated using 12 healthy adult volunteers as controls. Patients had been maintained on HPN for a mean of 36 months and averaged 121 cm of residual small bowel. Prospective diet surveys in patients indicated a mean oral caloric intake of 902 kcal/day. The mean plasma selenium concentrations (microgram/g) were 0.044 in patients and 0.117 in controls (p less than 0.01). The erythrocyte glutathione peroxidase activities, as mumol of NADPH oxidized/g hemoglobin/min, averaged 11.01 in patients and 31.76 in controls (p less than 0.01). Four patients exhibited myalgic symptomatology suggestive of clinical selenium deficiency. No correlations could be ascertained between plasma selenium levels and glutathione peroxidase activities in either patients or controls. Additionally, in the patient group, no significant correlations could be ascertained between selenium status and oral caloric intake, residual small bowel length, symptomatology suggestive of deficiency or HPN duration. However, since sample size was not large, lack of correlations might best be considered suggestive not conclusive. The data indicate that HPN patients with small bowel resections exhibit suboptimal selenium status and may be at risk of developing clinically evident selenium deficiency. HPN patients should be prophylactically supplemented with selenium regardless of oral intake, duration of HPN, or residual length of resected small bowel.
Journal of Parenteral and Enteral Nutrition | 1984
Richard J. Baptista; Margaret A. Lahey; Bruce R. Bistrian; Charlotte D. Champagne; Donald G. Miller; Susan E. Kelly; George L. Blackburn
Home parenteral nutrition (HPN) patients need periodic reassessment for compliance, appropriateness of parenteral formulation, infusion regimen, bowel adaptation, and effective oral nutrient intake. Additionally, new technological advances need to be considered for potential use in the home parenteral nutrition population. Since costs for home parenteral nutrition therapy are substantial, cost-effective options should be exercised whenever reasonable. The following case illustrates our approach to the reassessment process, subsequent modifications, and resultant impact on the lifestyle, adequacy, and cost of home parenteral nutrition therapy.
Journal of The American College of Nutrition | 1985
G Carle; John L. Duncan; S Thomson; Charlotte D. Champagne; L Buchanan; M Keane; Bruce R. Bistrian
A new device for assessment of delayed cutaneous hypersensitivity using seven standardized antigens (Multitest CMI) was compared to conventional intradermal testing with two recall antigens in 83 patients referred for nutritional support. Sixteen patients (19.3%) were anergic to Multitest CMI while four (4.8%) were anergic to conventional testing. Patients anergic to Multitest CMI had a higher complication (intraabdominal abscess, prolonged ileus, sepsis, pneumonia) than those who were immunocompetent by this test suggesting a group at greater risk. This interpretation is consistent with an increased specificity of Multitest CMI over conventional testing in the identification of clinically important anergy.
Surgery | 1986
Murray Bern; Albert Bothe; Bruce R. Bistrian; Charlotte D. Champagne; Mary S. Keane; George L. Blackburn
The American Journal of Clinical Nutrition | 1984
Richard J. Baptista; Bruce R. Bistrian; George L. Blackburn; Donald G. Miller; Charlotte D. Champagne; L Buchanan
Clinical pharmacy | 1983
Griffin Re; Charlotte D. Champagne; Bruce R. Bistrian; DiPalma Sa; Blackburn Gl; Peter N. Benotti
Nutrition | 1992
Daley Bj; Maliakkal Rj; Dreesen Eb; Charlotte D. Champagne; Ellison M; Thibault Sa; Forse Ra; Bruce R. Bistrian
Nutrition in Clinical Practice | 1987
Richard J. Baptista; George L. Blackburn; Charlotte D. Champagne; Donald G. Miller; Bruce R. Bistrian
Journal of Parenteral and Enteral Nutrition | 1988
Charlotte D. Champagne